Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sight Sciences, Inc.

4.21
-0.0200-0.47%
Post-market: 4.210.00000.00%16:04 EDT
Volume:62.79K
Turnover:264.41K
Market Cap:220.47M
PE:-4.39
High:4.23
Open:4.22
Low:4.09
Close:4.23
52wk High:7.05
52wk Low:2.03
Shares:52.37M
Float Shares:28.82M
Volume Ratio:0.60
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9597
EPS(LYR):-1.0274
ROE:-57.10%
ROA:-22.40%
PB:3.15
PE(LYR):-4.10

Loading ...

Paul Badawi, President and CEO, Reports Disposal of Common Shares of Sight Sciences Inc

Reuters
·
Jul 08

CFO Alison Bauerlein Reports Disposal of Common Shares in Sight Sciences Inc

Reuters
·
Jul 08

Matthew Link, Chief Commercial Officer, Reports Disposal of Common Shares in Sight Sciences Inc

Reuters
·
Jul 08

Sight Sciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Jun 18

Piper Sandler Reaffirms Their Hold Rating on Sight Sciences (SGHT)

TIPRANKS
·
Jun 18

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sight Sciences (SGHT) and Cullinan Management (CGEM)

TIPRANKS
·
Jun 17

Sight Sciences: Hold Rating Amid Promising TearCare Potential and Market Access Challenges

TIPRANKS
·
Jun 17

Sight Sciences Holds Annual Stockholders Meeting

TIPRANKS
·
Jun 06

Sight Sciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 06

Director and 10% Owner Staffan Encrantz Reports Acquisition of Common Shares in Sight Sciences Inc

Reuters
·
Jun 04

Director and 10% Owner Staffan Encrantz Reports Acquisition of Sight Sciences Common Shares

Reuters
·
May 30

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
May 23

CFO Alison Bauerlein Reports Disposal of Common Shares of Sight Sciences Inc

Reuters
·
May 22

Piper Sandler Sticks to Its Hold Rating for Sight Sciences (SGHT)

TIPRANKS
·
May 09

Sight Sciences Is Maintained at Hold by Lake Street

Dow Jones
·
May 09

Sight Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Sight Sciences Reports Q1 2025 Financial Results

TIPRANKS
·
May 09

Sight Sciences Q1 EPS $(0.28) Beats $(0.30) Estimate, Sales $17.51 Miss $16.51M Estimate

Benzinga
·
May 09

Press Release: Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

Dow Jones
·
May 09

BRIEF-Sight Sciences Q1 Revenue USD 17.5 Million Vs. IBES Estimate USD 16.5 Million

Reuters
·
May 09